# A Study of BEBT-908 in Combination With Chemotherapy in Patients With Previously Untreated Peripheral T-Cell Lymphoma (PTCL)

> **NCT07676175** · PHASE2 · NOT_YET_RECRUITING · sponsor: **BeBetter Med Inc** · enrollment: 120 (estimated)

## Conditions studied

- Previously Untreated Peripheral T-Cell Lymphoma

## Interventions

- **DRUG:** Ifupinostat Hydrochloride for Injection
- **DRUG:** Cyclophosphamide for Injection
- **DRUG:** Doxorubicin Hydrochloride for Injection
- **DRUG:** Vincristine Sulfate for Injection
- **DRUG:** Prednisone Acetate Tablets

## Key facts

- **NCT ID:** NCT07676175
- **Lead sponsor:** BeBetter Med Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2028-01-31
- **Final completion:** 2028-06-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-06-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07676175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07676175, "A Study of BEBT-908 in Combination With Chemotherapy in Patients With Previously Untreated Peripheral T-Cell Lymphoma (PTCL)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07676175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*